Geropharm opens new insulin pen assembly line in Obolensk

Russian pharmaceutical company Geropharm invested 163 million rubles to open a new assembly line for insulin injection pens at its facility in Obolensk, Moscow region. The line adds capacity of 7 million pens per year, increasing total capacity to 21 million pens annually.

“Производственная мощность предприятия увеличится до 21 млн инъекторов ежегодно”gxpnews.net

• 1 source
• gxpnews.net«Герофарм» за 163 млн рублей открыл новый участок по сборке шприц-ручек с инсулином | Новости | GxP NewsОт GxP NewsAug 23, 2023

Summarized from public sources; check the original articles before acting on it.